Table 1.
CgA | ProGRP | NSE | NSE adjusted | SCCA1 | |
PNET–HealthyThreshold value AUC PSensitivity (%)Specificity (%)PPV (%)NPV (%) | 1333.30.582NS39.187.575.060.0 | 95.20.7480.00160.910010072.7 | 40.90.6830.02747.895.891.765.7 | 12.70.7280.00360.987.582.470.0 | 49.30.599NS37.587.075.057.1 |
PNET–BenignThreshold value AUC PSensitivity (%)Specificity (%)PPV (%)NPV (%) | 1564.20.519NS56.560.056.560.0 | 87.30.7340.00360.992.087.571.9 | 51.10.584NS47.810010067.6 | 25.40.6890.01847.810010067.6 | 59.90.546NS40.091.383.358.3 |
PNET–NSCLCThreshold value AUC PSensitivity (%)Specificity (%)PPV (%)NPV (%) | 1404.90.547NS60.957.153.864.0 | 84.60.6990.01660.989.382.473.5 | 54.00.530NS47.878.664.764.7 | 35.30.586NS47.882.168.765.7 | 23.30.502NS71.443.560.655.6 |
*: Given as mean ± standard deviation. #: The age differences were statistically significant; the reason for this significance was the fact that the average age of healthy participants was lower than that of the patients in the NSCLC and benign groups (P < 0.05). &: The difference was statistically significant (P < 0.05). π: The difference was not statistically significant (P > 0.05).